| No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
| 1 |
chr17:66539200-66588000 |
Weak transcription |
iPS-15b Cell Line |
embryonic stem cell
|
| 2 |
chr17:66551800-66587800 |
Weak transcription |
H1 Cell Line |
embryonic stem cell
|
| 3 |
chr17:66552000-66584200 |
Weak transcription |
ES-I3 Cell Line |
embryonic stem cell
|
| 4 |
chr17:66552000-66585200 |
Weak transcription |
HUES48 Cell Line |
embryonic stem cell
|
| 5 |
chr17:66571200-66578000 |
Weak transcription |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
| 6 |
chr17:66572000-66578400 |
Enhancers |
NHDF-Ad |
bronchial
|
| 7 |
chr17:66572200-66577600 |
Enhancers |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
| 8 |
chr17:66572200-66591800 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
| 9 |
chr17:66572400-66577400 |
Enhancers |
Adipose Nuclei |
Adipose
|
| 10 |
chr17:66572600-66581200 |
Weak transcription |
Gastric |
stomach
|
| 11 |
chr17:66572800-66582800 |
Weak transcription |
Brain Angular Gyrus |
brain
|
| 12 |
chr17:66573400-66577200 |
Weak transcription |
NHLF |
lung
|
| 13 |
chr17:66573600-66578000 |
Weak transcription |
Right Atrium |
heart
|
| 14 |
chr17:66573800-66578200 |
Weak transcription |
Placenta |
Placenta
|
| 15 |
chr17:66574000-66576600 |
Weak transcription |
Placenta Amnion |
Placenta Amnion
|
| 16 |
chr17:66575200-66576800 |
Flanking Active TSS |
Liver |
Liver
|
| 17 |
chr17:66575200-66577200 |
Enhancers |
Fetal Thymus |
thymus
|
| 18 |
chr17:66575200-66577400 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
| 19 |
chr17:66575400-66576800 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
| 20 |
chr17:66575400-66577000 |
Enhancers |
Esophagus |
oesophagus
|
| 21 |
chr17:66575400-66577200 |
Enhancers |
Ovary |
ovary
|
| 22 |
chr17:66575600-66577400 |
Bivalent Enhancer |
Fetal Muscle Leg |
muscle
|
| 23 |
chr17:66575800-66576600 |
Enhancers |
H9 Derived Neuron Cultured Cells |
ES cell derived
|
| 24 |
chr17:66575800-66579400 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
| 25 |
chr17:66576000-66576600 |
Flanking Active TSS |
HepG2 |
liver
|
| 26 |
chr17:66576000-66577200 |
Enhancers |
Colon Smooth Muscle |
Colon
|
| 27 |
chr17:66576000-66577400 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
| 28 |
chr17:66576000-66577400 |
Enhancers |
Fetal Lung |
lung
|
| 29 |
chr17:66576000-66578000 |
Enhancers |
Osteobl |
bone
|
| 30 |
chr17:66576000-66578400 |
Weak transcription |
Pancreas |
Pancrea
|
| 31 |
chr17:66576200-66576800 |
Flanking Active TSS |
Monocytes-CD14+_RO01746 |
blood
|
| 32 |
chr17:66576200-66578000 |
Weak transcription |
HUES6 Cell Line |
embryonic stem cell
|
| 33 |
chr17:66576200-66581800 |
Weak transcription |
Lung |
lung
|
| 34 |
chr17:66576200-66581800 |
Weak transcription |
Skeletal Muscle Female |
skeletal muscle
|
| 35 |
chr17:66576400-66576800 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
| 36 |
chr17:66576400-66577000 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
| 37 |
chr17:66576400-66577000 |
Bivalent Enhancer |
Primary neutrophils fromperipheralblood |
blood
|
| 38 |
chr17:66576400-66577000 |
Enhancers |
Fetal Adrenal Gland |
Adrenal Gland
|
| 39 |
chr17:66576400-66577400 |
Enhancers |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
| 40 |
chr17:66576400-66577400 |
Enhancers |
Spleen |
Spleen
|
| 41 |
chr17:66576400-66581000 |
Weak transcription |
H9 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
